Expert Guidance on Treatment Advances in Acute Myeloid Leukemia

Join us for a live local workshop on managing AML with immunotherapeutic agents and novel targeted agents and planning therapy for older patients patients with comorbidities and those who do not have hematopoietic stem cell transplantation. Downloadable slidesets and an on-demand webcast will also be available.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Astellas Text

Bristol Myers Squibb

Genentech, a member of the Roche Group

Jazz Pharmaceuticals, Inc.